MedTrace Logo

A PK Study to Evaluate PUR0200 and a Reference Product in Healthy Subjects

NCT02671825 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2016-11-11

No results posted yet for this study

Summary

The purpose of this study is to compare drug blood levels of multiple formulations of inhaled PUR0200 to each other and to the reference product with and without oral charcoal.

Conditions

  • Healthy

Interventions

DRUG

PUR0200

PUR0200 dry powder inhalation

DRUG

Reference Product

Dry Powder Inhalation Reference Product

Sponsors & Collaborators

  • Pulmatrix Inc.

    lead INDUSTRY

Principal Investigators

  • Valentin Kirkov, MD · Tokuda Hospital

  • David Hava, PhD · Pulmatrix Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Bulgaria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02671825 on ClinicalTrials.gov